Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China - Takeaways - MDSpire

Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China

  • By

  • Hongzhan Cui

  • Jiao Wang

  • Tengyue Zhao

  • Hongjuan Liao

  • Jieqiong Zhang

  • Luyu Li

  • Ce Feng

  • Hongyu Xiao

  • Jialu Li

  • Ziying Chen

  • June 15, 2026

  • 0 min

Share

  • 1

    Transcatheter PFO closure in Chinese migraine patients showed an overall responder rate of 83.98%, with 59.9% achieving complete relief.

  • 2

    Younger patients aged 15–24 years had the highest responder rate of 89.67%, indicating age as a strong predictor of treatment success.

  • 3

    More recent procedural years independently predicted higher success rates, reflecting a significant learning curve in the procedure.

  • 4

    The procedure demonstrated a 100% technical success rate, with only 3.49% minor complications and no major adverse events reported.

  • 5

    Sustained therapeutic benefits were observed after DAPT discontinuation, with an 81.93% responder rate at over 12 months post-procedure.

Original Source(s)

Transcatheter patent foramen ovale closure achieves high efficacy in migraine patients: a single-center retrospective cohort study in China

  • by Hongzhan Cui, Jiao Wang, Tengyue Zhao, Hongjuan Liao, Jieqiong Zhang, Luyu Li, Ce Feng, Hongyu Xiao, Jialu Li, Ziying Chen

  • June 15, 2026

Related Content

Case Report: Paradoxical worsening of hypoxemia with PEEP during one-lung ventilation: a case of pressure-dependent intracardiac shunting

A case report of a rare and distinctive pacing pattern during left bundle branch pacing in a child with third-degree atrioventricular block following ventricular septal defect repair

Emergency criteria and lifesaving intervention windows for high-risk critical congenital heart disease: a perspectives